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ABSTRACT
It is critical to discover the mechanisms of normal cell cycle regulation if we are to fully
understand what goes awry in cancer cells. The normal eukaryotic cell tightly regulates
the activity of origins of DNA replication so that the genome is duplicated exactly once
per cell cycle. Over the last ten years much has been learned concerning the cell cycle
regulation of origin activity. It is now clear that the proteins and cell cycle mechanisms
that  control  origin  activity  are  largely  conserved  from  yeast  to  humans.  Despite  this
conservation, the composition of origins of DNA replication in higher eukaryotes remains
ill defined. A DNA consensus for predicting origins has yet to emerge, and it is of some
debate whether primary DNA sequence determines where replication initiates. In this
review we outline what is known about origin structure and the mechanism of once per
cell cycle DNA replication with an emphasis on recent advances in mammalian cells. We
discuss the possible relevance of these regulatory pathways for cancer biology and therapy.
The complete duplication of chromosomes during S phase is required for their proper
segregation in mitosis, and ensures that each daughter cell receives a full genome complement.
To accomplish this important and large task in a short time, the eukaryotic cell begins
DNA replication from numerous origins. Cell cycle checkpoints exist that restrain mitosis
if DNA replication is not complete. To avoid genomic instability, however, it is also important
that each genomic region is replicated no more than once per cell cycle. Below we concisely
review the current model of how the cell regulates origins of DNA replication so that the
genome is duplicated exactly once per cell cycle. We discuss the progress and challenges
ahead for understanding this process in mammalian cells and its possible relevance to cancer.
For in depth discussions of various topics concerning the cell cycle regulation of DNA
replication, the interested reader is referred to several excellent recent reviews.1-3
It has been more than 30 years since the mammalian cell fusion studies of Rao and
Johnson showed that cells in different phases of the cell cycle have different competencies
for replicating their genome.4 When fused with an S phase cell, a G1 nucleus will begin
to synthesize its DNA whereas a G2 nucleus will not. We now know that the diffusible
factors in S phase cells that induce DNA replication are Cyclin Dependent Kinase 2
(CDK2) with its associated activating cyclin subunits, Cyclin E or Cyclin A (see Table 1).5
The absence of DNA replication in the G2 nucleus, however, suggested the existence of a
cell cycle regulation that blocks re-replication once cells have passed through S phase. 
Over the last ten years it has become clear that the essential aspect of once per cell cycle
DNA replication is that it occurs in two steps. Proteins bind to origins in G1, followed by
activation of those proteins to initiate replication in S phase. Upon initiation, these proteins
leave origin DNA. Mechanisms that inhibit rebinding of these proteins in S, G2, and M
ensure that origins are competent to initiate only once per cell cycle, explaining why an S
phase nucleus cannot stimulate a G2 nucleus to re-replicate. 
PREPARING FOR S PHASE: BUILDING THE PRE-RC
The first step in DNA replication is the building of a pre-Replicative Complex of proteins
(pre-RC) onto origins in early G1. Much of what we know about the proteins of the pre-
RC was initially learned through studies in the budding yeast Saccharomyces cerevisiae.3,6 It
is now clear, however, that these proteins are conserved among all eukaryotes, including
humans.1
Assembly of the pre-RC in G1 occurs stepwise. First, the six subunit Origin Recognition
Complex (ORC) binds to origin DNA (Figure 1). In yeast, ORC proteins remain bound
to the origin throughout the cell cycle.7 Next, cell division cycle protein 6 (CDC6) associates
with the ORC, and acts to load the Mini-Chromosome Maintenance (MCM) proteins onto
the pre-RC.8,9The MCM proteins (2-7) form a six-subunit heteromeric complex which isGENOME DUPLICATION
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thought to be the replicative helicase.10,11 Recently it was shown
that  another  protein,  CDT1,  also  associates  with  ORC  and  is
required  to  load  the  MCM  complex  onto  chromatin.12,13
Homologues of CDT1 have now been found in a wide range of
eukaryotes,  including  humans.14,15 Once  the  MCMs  are  loaded
onto  chromatin  in  G1,  the  pre-RC  is  complete  and  origins  are
considered to be “licensed” for replication.16 In fact, if ORC and
CDC6 proteins are extracted from Xenopus nuclei in vitro, MCMs
remain bound to chromatin and nuclei remain competent to initiate
replication.17
INITIATION OF DNA REPLICATION
S phase begins with the activation of the pre-RC and the initiation
of DNA replication. This occurs due to a rise in CDK activity late
in G1, and requires another kinase, CDC7, with its activating sub-
unit DBF4.18,19 Phosphorylation of MCM proteins by CDC7 is
required for activation of the pre-RC.20 In S. cerevisiae and the fission
yeast, S. pombe, a single CDK kinase is activated by different B type
cyclins.6,21 In higher eukaryotes, the S phase CDK activity is contributed
by Cyclin E/CDK2 (CycE/CDK2) and Cyclin A/CDK2 (CycA/CDK2)
complexes. CycE/CDK2 stimulates S phase in part by phosphorylation
of the retinoblastoma protein (RB).22This overcomes the inhibition
of RB on the E2F/DP transcription factors, resulting in production
of  proteins  required  for  S  phase.  Evidence  also  suggests  that
CycE/CDK2 and CycA/CDK2 phosphorylate other targets, including
subunits of the pre-RC.23 In the yeasts S. cerevisiae and S. pombe,
these targets include CDC6 and subunits of the ORC and MCM
complex. With CDK activation, two proteins associate with the pre-
RC: CDC45 and SLD3.24,25 These proteins associate with MCMs
and are required for loading of the single-stranded DNA binding
protein,  RPA,  and  DNA  polymerase-alpha:DNA  primase,  which
begins DNA synthesis.26,27 In higher eukaryotes phosphorylation of
the  pre-RC  subunits  and  initiation  is  dependent  on  CDKs  and
CDC7.28,29 However, the precise biochemical mechanism by which
phosphorylation stimulates initiation remains unclear. 
THE BLOCK TO RE-REPLICATION
To avoid unbalanced replication of the genome, it is important
that origins initiate replication only once per cell cycle (Figure 2).
After initiation, CDC6, CDT1 and MCMs dissociate from origin DNA.2
The block to re-initiation is accomplished by inhibiting reassociation of
these proteins with origin DNA in S, G2, and M. Although CDKs
stimulate initiation by phosphorylating subunits of the pre-RC, this
also leads to dissolution of the complex, and inhibits rebinding to
origins.30 In S. cerevisiae, phosphorylation leads to degradation of
CDC6 (CDC18 in S. pombe) by ubiquitin-mediated proteolysis,
and the nuclear export of MCM proteins.31,32 In vertebrate cells,
this regulation is similar but modified. Phosphorylation of CDC6
by  CycA/CDK2  leads  to  its  nuclear  export,  and  phosphorylated
MCMs remain in the nucleus but dissociated from chromatin.1,33,34
Although ORC remains bound to origins in S. cerevisiae, its phos-
phorylation appears also to inhibit pre-RC reassembly.35 In higher
eukaryotes, certain subunits of the ORC become destabilized from
the complex after initiation, providing another possible mechanism
by which re-replication is blocked.28
A recent report elegantly demonstrated that the blocks to pre-RC
assembly and reinitiation are multiply redundant, emphasizing the
importance of this inhibition to the cell. Nguyen et al, showed that
overcoming the CDK inhibition on ORC, CDC6, and MCMs, singly or
pairwise, was insufficient to induce re-replication in S. cerevisiae.35 It
was only when all three blocks were overcome that the cell re-replicated
its DNA in G2. Similarly, in higher eukaryotes, mutation of the
CDK2 phosphorylation sites on CDC6 results in its nuclear retention,
but this is insufficient to stimulate re-replication.36,37 Thus it appears
that the cell has evolved multiply redundant mechanisms to avoid
unbalanced replication and genomic catastrophe. 
This redundancy is further emphasized by the finding in vertebrate
cells that another mechanism besides CDK phosphorylation also
inhibits  pre-RC  assembly.  This  mechanism  is  mediated  by  the
Geminin protein. Addition of excess Geminin to the Xenopus in
vitro  replication  system  blocks  DNA  replication  and  chromatin
association of MCMs.38 Recently it was shown that human Geminin
protein inhibits pre-RC assembly in these in vitro extracts by binding
CDT1 and blocking its ability to load the MCM complex.3,14,39
Because Geminin is abundant in S, G2 and M, it may be an important
guardian of genomic stability in human cells. It is only after Cyclins
and Geminin become targeted for degradation at the end of mitosis
that a cell can re-assemble the pre-RC in preparation for another
S phase. Why a cell would need Geminin, however, in addition to
the other multiply redundant blocks to re-replication, remains an
important question.
Table 1 A LEXICON OF ABBREVIATIONS FOR PROTEINS INVOLVED
IN THE CONTROL OF ORIGIN ACTIVITY
Protein Function
ORC Heterohexameric Origin Recognition Complex.
Binds to origin DNA. Part of the pre-Replicative
Complex (pre-RC).
CDC6 Associates with ORC in G1 and is required for
loading the MCM complex. Part of the pre-RC.
CDT1 Associates with ORC in G1 and is required to load
the MCM complex. Part of the pre-RC.
MCM Heterohexameric Mini-Chromosome Maintenance
complex. Putative replicative helicase. Part of the
pre-RC.
CDC45 Associates with MCMs in the pre-RC dependent
upon CDKs. Required for loading RPA and DNA
polymerase-alpha: DNA primase.
RPA Replication Protein A. Single-stranded DNA binding
protein complex.
Cyclin E/CDK2 Cyclin Dependent Kinase 2 with its activating sub
Cyclin A/CDK2 units Cyclin E or Cyclin A. Stimulate entry into and
through S phase. 
CDC7/DBF4 CDC7 kinase with its activating subunit DBF4.
Required throughout S phase for origin activation.
Geminin Negative regulator of pre-RC formation. Binds to
CDT1 and blocks MCM loading.
RB Retinoblastoma. The founding member of a family of
“pocket proteins” that bind to and inhibit the activity
of E2F/DP transcription factors. Phosphorylation of
RB by Cyclin D/CDK4 or CDK6 followed by Cyclin
E/CDK2 leads to release of E2F/DP and entry into
S phase.
E2F/DP A heterodimeric transcription factor. Different mem-
bers of this protein family have diverse functions
including transcription of genes required for DNA
replication.
CycD/CDK4 Two major Cyclin Dependent Kinase complexes 
CycD/CDK6 active in G1. Major phosphorylation target is RB.WHAT IS AN ORIGIN IN MULTICELLULAR EUKARYOTES?
In S. cerevisiae, what comprises an origin of DNA replication is
relatively well defined. These origins were originally identified by
testing segments of DNA for their ability to confer replicative com-
petence to an extrachromosomal episome, and are called autonomously
replicating sequences (ARSs).40 Some were subsequently shown to
be  origins  of  DNA  replication  in  their  natural  position  on  the
chromosome. Budding yeast origins are relatively small in size (100-150
bp) and contain multiple functional subsequences. The most highly
conserved is the ARS Consensus Sequence (ACS), which is part of
the binding site for the ORC. Another subsequence constitutes what
is thought to be the DNA unwinding element (DUE), the putative
site where DNA unwinding begins. Some origins also contain a sub-
sequence that binds the transcription factor Abf1, which stimulates
replication initiation. A recently developed high resolution mapping
technique, Replication Initiation Point mapping (RIP), has shown
that bidirectional replication begins at a site flanking the ORC binding
site in ARS1.41
Over  30  years  ago,  microscopic  visualization  of  radioactive
nucleotide incorporation indicated that replication begins on mammalian
chromosomes  from  bidirectional  origins  of  DNA  replication.42
Origins of DNA replication in multicellular eukaryotes (the metazoa),
however, remain ill defined relative to those in budding yeast.28 A
DNA consensus for predicting origins or where the pre-RC will bind
has yet to emerge. An ARS assay equivalent to that in yeast has not
aided identification of origins in higher eukaryotes. The size of the
DNA  fragment  appears  to  be  more  important  than  the  DNA
sequence for determining replication competence in frog extracts or
cells in culture. Consequently, a number of biochemical methods
have been used to map the physical site at which DNA synthesis
initiates.  Some  of  these  methods  map  origins  by  identifying  the
sequences that are replicated first in S phase, or rely on the switch
from leading and lagging strand replication on the two sides of the
initiation site by analyzing Okazaki fragments.43 Start points for
replication have also been mapped by two-dimensional agarose gels
which exploit the different migration patterns of replication inter-
mediates.28The current view is that metazoan origins contain preferred
sites of initiation, used in most cell cycles, surrounded by a region
that contains less frequently used sites. If the preferred site of initiation
is  compromised,  replication  can  initiate  at  these  secondary  sites.
Application of the high resolution RIP mapping technique to the origin
at the human lamin B locus confirms that bi-directional replication
initiates at a precise and conserved site in most cell cycles.44
A small number of origins have also been subjected to genetic
mapping in an effort to identify the sequences essential for activity.40
In these assays, origin activity is measured after insertion of the putative
origin into an ectopic chromosomal site or deletion of sequences at
the natural locus. The general theme that has emerged is that origins
in metazoa are larger and more complex than those in budding yeast.
Even in the yeast S. pombe, functional origins have been shown to be
~1 kb, with multiple stretches of AT-rich sequences that are required
for  function,  but  no  easily  identifiable  consensus  sequence.45 In
mammalian cells, sequences as far as 50 kb away can influence the
frequency of initiation of an origin. The stable association of ORC
with bulk chromatin in G1 correlates with the establishment of origin
identity in mammalian cells.46 It remains a mystery, however, how
the pre-RC is stably associated with only some regions on metazoan
chromosomes.  It  appears  that  ORC  in  higher  eukaryotes  has  a
relaxed binding specificity, and therefore biochemical methods that
rely on mapping the interaction sites of ORC with DNA have not
been  informative  for  identifying  origins.  Evidence  suggests  that
chromatin structure, and not just DNA sequence, may be a large
factor in determining where the pre-RC will bind and replication
will initiate.47 The number and identity of origins can change during
development and this correlates with changes in chromosome structure.
When moved to ectopic genomic positions, the chromosomal context
of an origin can greatly affect its ability to fire. However, genetic
GENOME DUPLICATION
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Figure 1. The pre-Replicative Complex (pre-RC) and S phase kinases. In G1, CDT1 and CDC6 proteins associate with ORC at origins and load the MCM
complex. Later, this pre-RC is activated to initiate DNA replication through the action of DBF4/CDC7 kinase and the CDK complexes CycA/CDK2 and
CycE/CDK2. See text and Table 1 for details and abbreviations. GENOME DUPLICATION
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analyses have also shown that the activity of certain metazoan origins
does depend on some specific DNA subsequences, believed to direct
the assembly of the pre-RC.28 The ability to insert wild-type or
mutant versions of a mammalian origin into the same genomic site
by using site specific recombination systems is especially promising
for identifying sequences that are important for origin activity.48
DEVELOPMENTAL AMPLIFICATION: A MODEL SYSTEM
FOR ORIGIN IDENTITY AND REGULATION
Although progress is being made in human cells, model organisms
continue to contribute to the investigation of origin composition
and  regulation. Two  of  these  model  organisms  are  the  fruit  fly
Drosophila melanogaster and the fungus fly Sciara coprophila. In these
two flies, genes become amplified through re-replication at specific
times in development. In Drosophila, two loci of eggshell (chorion)
protein genes are amplified in the ovary to support rapid synthesis of
the eggshell.49 Sequences from these loci can direct amplification in
the fly ovary when transformed into ectopic genomic sites. This has
facilitated the genetic mapping of subregions at the chorion locus
that are essential for amplification. Two of these subregions were
shown to bind to fly ORC in vitro and in vivo, the first demonstration
of specific ORC binding in metazoa.50 The genetics of the fruit fly
has  also  contributed  to  our  understanding  of  origin  regulation.
Genes that are required for the activity of these origins have a distinct
mutant phenotype; females lay eggs with thin eggshells due to a defect
in amplification. The molecular identification of these genes over the
last few years has revealed that amplification origins are regulated by
proteins known to be critical for G1/S phase progression.51 These
include proteins of the pre-RC and the S phase kinases CycE/CDK2
and CDC7/DBF4. This suggests that a continued search for muta-
tions that cause thin eggshells, combined with the molecular and
genetic tools available in Drosophila, will provide insight into origin
regulation. 
In Sciara, amplification increases copy number of genes in the larva
during  metamorphosis.  This  robust  developmentally-programmed
re-replication has facilitated molecular mapping of the origin at the
Sciara II/9A locus. A recent elegant report of ORC binding and RIP
mapping at the II/9A locus indicates that replication initiates adjacent
to the ORC binding site as it does in S. cerevisiae.52 This encourages
the idea that although the regulation is likely more complex in metazoa,
the basic mechanism for pre-RC activation and replication initiation
is conserved with yeast. To date, the chorion locus of Drosophila and
the II/9A locus of Sciara are the two origins in metazoa for which ORC
binding has been shown. Given that these loci are developmentally
amplified, however, it is still an open question as to how similar these
origins are to those that control chromosome duplication duringother
cell  cycles.  Nonetheless,  these  two  systems  are  among  the  most
promising for clarifying the hazy picture of origin composition and
pre-RC regulation in metazoa.
Figure 2. The control of once per cell cycle DNA replication. The pre-RC, comprised of ORC, CDT1, CDC6 and the MCM complex, forms on origins in
early G1 when CDK activity is low. In S phase, CDC7 and CDKs stimulate the pre-RC to initiate DNA replication, likely by phosphorylating multiple sub-
units (arrows). Upon initiation, CDC6 and CDT1 dissociate from chromatin and the MCM complex is thought to travel with the replication forks and act as
the replicative helicase. During S, G2, and M phases, the pre-RC can not reform due to the persistence of CDK activity and the negative inhibitor Geminin.
The pre-RC can reassemble when cyclins and Geminin are degraded upon completion of mitosis. This restricts origin firing to once per cell division.WHAT IS THE ROLE OF DNA REPLICATION CONTROL
IN THE CANCER CELL?
The decision to enter a round of cell division begins in G1 with the
commitment to enter S phase and activate origins of DNA replication.
Mutation or amplification of genes required for normal G1/S phase
progression are frequent causes of cancer. Thus it is important to ask
what role proteins associated with origins play in the cancer cell. In
this regard it is important to note that, unlike yeast and flies, in
mammalian cells ORC1 and ORC6 are less tightly associated with
the other ORC subunits, and it has been problematic to isolate a
holocomplex from cancer cell lines.53-57 It is therefore an interesting
possibility that formation of the ORC holocomplex plays a role in
the cell cycle regulation of origin firing in normal and cancer cells.
The human ORC5L gene resides in a chromosomal region that is
deleted in a subset of uterine leiomyomas, adult myeloid leukemias,
and myelodysplastic syndrome.58 It is not clear that ORC5L is relevant
to disease, however, because DNA sequencing and expression analysis
from myeloid leukemia patients that are heterozygous for the locus
did  not  find  evidence  for  point  mutation  or  imprinting  of  the
undeleted allele of the ORC5L gene.59 To date there is no evidence
for mutation or amplification of the pre-RC proteins themselves in
human cancers. One explanation for this could be that these proteins
act as large heteromeric complexes that must be activated by CDKs.
Upregulation of CDK activity or mutation of the RB negative regulator
are frequent in cancer cells. Recent reports suggest that RB protein
is  localized  to  sites  of  DNA  replication  in  vertebrate  cells.60 In
Drosophila, an RB related protein associates with ORC at chorion
amplification origins and negatively regulates DNA replication.61
This suggests that hyperactivation of the pre-RC may be a direct target
of aberrant G1/S phase progression in cancer cells with mutated RB
or upregulated CDKs.
In addition to cellular CDKs, those encoded by viruses can subvert
normal cell cycle regulation. Kaposi’s sarcoma-associated herpes virus
(KSHV) and herpesvirus saimiri, associated with T cell lymphomas in
primates, encode a cyclin D homolog that complexes with cellular
CDK6 and targets a number of cell cycle regulatory molecules, such
as RB, thereby stimulating cell proliferation.62 It was recently shown
that viral CycD/CDK6 phosphorylates pre-RC subunits ORC1 and
CDC6, and can promote the initiation of DNA replication in vitro.63
Thus  it  appears  that  the  multi-pronged  attack  of  these  cancer-
associated viruses on the cell cycle includes the proteins bound to
origins leading directly to the initiation of DNA replication.
Abundant expression of the pre-RC and associated proteins is
essential  to  support  the  proliferation  of  the  cancer  cell.  Indeed,
quiescent G0 cells that have withdrawn from the cell cycle are unable
to form functional pre-RCs, possibly as a redundant mechanism to
ensure cell cycle arrest.64 When G0 cells re-enter the cell cycle in
neoplastic disease states, pre-RC components and other DNA replication
genes are abundantly expressed. In fact, antibodies against MCM5
and CDC6 proteins have proven to be sensitive diagnostic tools for
Papanicolaou (Pap) smear tests.65 Therefore, although mutation of
these proteins may not be sufficient for neoplastic disease, restraining
their activity could be one target for therapeutics. One potential
approach would be to inhibit the essential ATP binding and hydrolysis
functions of several of the pre-RC subunits through rational drug
design. Another potential approach could be to exploit the Geminin
protein as a natural inhibitor of pre-RC formation.66 The recent
finding that cellular pre-RC components are required for Epstein
Barr virus replication suggests that such an approach may be most
efficacious in those cancers to which Herpes viruses may contribute.66-68
Amplification of genes that promote cell division contributes to
the  proliferation  of  the  cancer  cell.69 An  important,  unanswered
question is to what extent re-replication at specific origins may be
part of the mechanism for amplification. Amplification in cancer
cells involves genetic rearrangement into minute chromosomes or
homogeneously staining regions that contain tandem copies of the
amplified gene. This is different from the programmed developmental
amplification in Drosophila and Sciara, which occurs by re-replication
without genetic rearrangement. It is possible, however, that early
events of genomic instability in the cancer cell could entail unregulated
origin firing, providing substrates for genetic recombination and further
amplification. Although this suggestion is highly speculative, it will
be interesting to see if further mapping of human origins of DNA
replication places them near loci that are known to be amplified in
cancer. One notable correlation is at the myc locus, which is one of
the well defined human origins and whose amplification contributes
to cancer. Other genes whose amplification contributes to cancer,
such as Cyclin D, have not had origins mapped near them.70 Clearly,
further mapping of origins of DNA replication in human cells is
needed  before  the  relationship  between  origin  regulation  and
genomic instability can be fully evaluated. 
CONCLUSION
The last ten years have witnessed great advances in discovering
how the cell controls the duplication of chromosomes. The challenge
ahead is to define what constitutes an origin of DNA replication in
higher eukaryotes, and to discover the full repertoire of cell cycle
regulation that stimulates replication only once per cell cycle. A central
remaining question is what dictates the binding of the pre-RC to
specific sites on chromosomes when origins are licensed for DNA
replication. To define the biochemical mechanism of initiation and
re-replication inhibition, it is important to identify all the targets of
Cyclin Dependent Kinases at origins of DNA replication. Moreover,
given that the block to re-replication by CDKs is multiply redundant,
why do cells encode the additional negative regulator Geminin? Is
this protein essential to regulate origin licensing in all cell cycles or
as part of a cell cycle checkpoint? It is important for us to answer
these and other questions regarding the cell cycle regulation of DNA
replication if we are to fully understand the cancer cell.
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